All Research
    PAPER ACCAHAGuideline2026

    2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia

    2026 multisociety dyslipidemia guideline (Circulation 2026;153:e1154-e1276): endorses a lifetime-exposure model for ApoB-containing lipoproteins and recommends ApoB selectively to identify residual risk after LDL-C/non-HDL-C goals are met or when measures are discordant; Lp(a) measured at least once (>=125 nmol/L or >=50 mg/dL as a risk-enhancing factor).

    Evidence

    —

    Not Rated

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    Circulation

    Jun 2026

    03

    Structured Methods

    Study Design
    Guideline
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (2026). 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. Circulation. https://doi.org/10.1161/CIR.0000000000001423

    05

    Indexing

    Biomarkers

    apob
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation